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Background—Health disparities have been associated with the prevalence of cardiovascular disease. In cardiac surgery,
association has been found between race, sex, and poorer prognosis after surgery. However, there is a complex interplay
between race, sex, and socioeconomic position (SEP). In our investigation we sought to identify which of these was the
driver of risk-adjusted survival.
Methods and Results—From January 1, 1995, and December 30, 2005, 23 330 patients (15 156 white men, 6932 white
women, 678 black men, and 564 black women) underwent isolated coronary artery bypass grafting, valve, or combined
coronary artery bypass grafting and valve procedures. Median follow-up was 5.8 years (25th and 75th percentiles: 3 and
8.6 years). Effect of race, sex, and SEP on all-cause mortality was examined with 2-phase Cox model and generalized
propensity score technique. As expected, blacks and women had lower SEP as compared with whites and men for all
6 SEP indicators. Patients with lower SEP had more atherosclerotic disease burden, more comorbidity, and were more
symptomatic. Lower SEP was associated with a risk-adjusted dose-dependent reduction in survival after surgery (men,
P0.0001; women, P0.0079), but black race, once adjusted for SEP, was not.
Conclusions—Our large investigation demonstrates that disparities in SEP are present and significantly affect health
outcomes. Although race per se was not the driver for reduced survival, patients of low SEP were predominantly
represented by blacks and women. Socioeconomically disadvantaged patients had significantly higher risk-adjusted
mortality after surgery. Further investigation and targeted intervention should focus specifically on patients of low SEP,
their health behaviors, and secondary prevention efforts. (Circ Cardiovasc Qual Outcomes. 2010;3:267-276.)
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It has been generally accepted that race and sex affectoutcomes of cardiac surgery: Blacks and women are
almost uniformly reported to have poorer prognosis than
whites and men. However, these obvious demographic
differences in skin color and sex (universally included in
our medical records) hide race sex diversity in socioeco-
nomic position (SEP). Metrics such as income, value of
housing, and level of education are considered sensitive,
private information that is rarely included in medical
records. Yet, SEP may be an important barrier to cardio-
vascular health rather than biologically implausible surro-
gates of race and sex. Therefore, our objectives were to (1)
examine race-sex–related differences in distribution of
SEP measures, (2) delineate its impact on mortality after
cardiac surgery, and (3) determine whether the true risk
factor was demographic or socioeconomic.
Women, black (versus white) racial groupings, younger pa-
tients and those with higher body mass index had lower overall
SEP (Table 2). Patients with lower SEP had more atherosclerotic
disease burden and serious cardiovascular disease with more
prior myocardial infarctions, more left ventricular dysfunction
and heart failure, and were more symptomatic, as represented by
higher New York Heart Association (NYHA) functional class.
In addition, they had more comorbidities, such as hypertension,
prior stroke, peripheral arterial disease, and treated diabetes, and




From January 1, 1995, to December 30, 2005, 23 330 patients
(15 156 white men, 6932 white women, 678 black men, and 564
black women) underwent isolated coronary artery bypass grafting
(CABG), isolated heart valve procedures, or combined CABG and
valve procedures at the Cleveland Clinic. Patients of other racial
groups, international patients, and patients for whom socioeconomic
position information were not available from the US Census Data-
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base were a small percentage of the total population and were
excluded from the statistical analysis (Figure 1). Race and sex were
self-reported by the patient on hospital admission, and the database
was populated with this information from the Cleveland Clinic’s
Master Patient Index. Patients were given the opportunity to refuse
documenting their race; these patients are represented in Figure 1 by
“unknown.” Race and sex were verified by the data abstractor and
entered into the Cleveland Clinic Cardiovascular Information Reg-
istry. Clinical variables and perioperative factors were also prospec-
tively collected concurrently with patient care by individuals trained
in database management and entered into the Cardiothoracic Anes-
thesia Registry. Additional clinical variables were obtained from the
Cardiovascular Medicine Information registries. All these databases
have been approved for use in research by our institutional review
board with individual patient consent waived.
Socioeconomic Position
From the 2000 US Census,1 we used census block socioeconomic
data, a geographical unit containing approximately 1000 residents, as
a surrogate for individual-level SEP.2 Overall neighborhood SEP
score was calculated with use of previously validated methods from
6 census block characteristics: median household income; median
value of housing unit; proportion of households receiving interest,
dividend, or net rental income; the proportion of adults 25 years of
age or older who had completed high school; proportion of adults 25
years of age or older who had completed college; and the proportion
of employed persons 16 years of age or older in executive, mana-
gerial, or professional specialty occupation.1 Each characteristic was
transformed into a standardized Z score by first subtracting its mean
and then dividing it by its standard deviation. It is customary to use
an overall Z score for SEP of census blocks by summing all 6
component Z scores with equal weights.1 Nevertheless, in this study
we validated this equal weighting approach with our data through a
principal component factor analysis of the 6 individual Z scores,
which identified a single principal component, expressed as a
weighted sum of the 6 Z scores, that can explain nearly 80% of the
variation in the data (data not shown). Weights for 6 Z scores were
similar, which justified the definition of the overall SEP Z score as
a summation of the individual Z scores.
End Point
The end point of this investigation was time to death (all-cause
mortality) after operation. Vital status was ascertained from the
Social Security Death Index (SSDI) with the closing date of August
27, 2007. The 23 330 patients had a median follow-up of 5.8 years
(25th and 75th percentiles: 3 and 8.6 years).
Statistical Methods
Patients were divided into 4 race-sex groups and compared: white
men, white women, black men, and black women (Table 1).
Continuous variables were summarized by median, 25th, and 75th
percentiles and tested by Wilcoxon rank-sum tests; categorical
variables were summarized by frequencies and percentages and
tested by 2 tests. The distribution of each of the 6 SEP character-
istics for the entire patient cohort or for the 4 racial sex subgroups
was summarized by histograms and cumulative density functions
(Figures 2, 3, and 4). Survival after surgery was by the Kaplan-Meier
method and subgroups were compared using the log-rank test
stratified on racial sex groups or SEP Z score levels (Figure 5). A
linear model was developed to identify demographic and clinical
variables associated with overall SEP Z score (Table 2). The list of
variables considered is provided in Online Data Supplement, Table
1. Because men and women naturally differ in many demographic
and clinical variables, and preliminary analyses suggested that there
might be complex interactions between sex and race, the primary
analyses were conducted among men and women separately, which
Figure 1. CONSORT-style diagram of
race and ethnicity groupings for the
patient population.
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included (1) propensity score matching between white men and black
men on a list of established confounders of mortality including SEP
Z score to study the causal effect of race among men; (2) similar
propensity score matching between white women and black women
to study the causal effect of race among women; (3) studying the
causal effect of SEP Z score among men by generalized propensity
score subclassification; and (4) studying the causal effect of SEP Z
score among women similarly. To further confirm the results
obtained from analyses (1) through (4) and to compare the relative
magnitude of causal effects of race and SEP, we conducted 2











Age, y 65 (56, 73) 68 (57, 75) 61 (53, 69) 61 (52, 70)
Body mass index, kg/m2 27.5 (24.9, 30.8)14 26.7 (23.1, 31.2)7 27.7 (24.9, 31.6)2 28.9 (25.1, 33.7)
Preoperative laboratory
Hematocrit, % 40.7 (3, 43.4)2246 36.4 (33, 39.6)992 38 (33, 41.4)106 35 (31.1, 38.3)74
Creatinine, mg/dL 1.1 (0.9, 1.3)305 0.9 (0.7, 1.1)139 1.2 (1, 1.5)10 1 (0.8, 1.2)16
Bilirubin, mg/dL 0.6 (0.5, 0.9)2741 0.5 (0.4, 0.8)1182 0.6 (0.4, 0.8)174 0.5 (0.3, 0.7)138
Cardiac morbidity
Prior myocardial infarction 6972 (46) 2478 (36)1 378 (56) 253 (45)
Abnormal LV function 8153 (54)56 3167 (45.9)30 448 (66.6)5 318 (56.8)4
Heart failure 4331 (28.6) 3021 (43.6) 295 (43.5) 306 (54.3)
NYHA functional class
1 2778 (18.3)4 848 (12.2)1 95 (14) 61 (10.8)
2 7823 (51.6) 3320 (47.9) 325 (47.9) 257 (45.6)
3 2465 (16.3) 1767 (25.5) 141 (20.8) 138 (24.5)
4 2086 (13.8) 996 (14.4) 117 (17.3) 108 (19.1)
Atrial fibrillation 1019 (6.72) 697 (10.1) 33 (4.87) 27 (4.79)
Carotid disease 4993 (32.9) 2608 (37.6) 195 (28.8) 181 (32.1)
Aortic valve regurgitation 4539 (30.6)303 2341 (35)242 183 (27.4)10 161 (29.4)17
Aortic valve stenosis 3007 (20.6)531 1889 (28.9)390 73 (11)12 75 (14)27
Mitral valve regurgitation 7947 (53.1)197 4650 (68)93 317 (47)3 357 (63.6)3
Mitral valve stenosis 259 (1.79)651 710 (10.8)335 10 (1.52)19 28 (5.18)23
Tricuspid valve regurgitation 4975 (33.9)487 3578 (53.7)270 221 (33.4)17 283 (51.7)17
Coronary disease 70% stenosis
Left main trunk 1570 (10.9)704 455 (7)429 62 (9.63)34 49 (9.46)46
Left anterior descending 8815 (60.9)688 2950 (45.3)416 435 (67.3)32 282 (54.4)46
Left circumflex 7670 (53.1)702 2448 (37.7)432 386 (59.8)32 240 (46.4)47
Right coronary artery 8150 (56.4)714 2691 (41.5)440 399 (61.9)33 258 (50)48
Comorbidity
Hypertension 9747 (66.4)485 4614 (68.4)189 580 (86.6)8 461 (83.1)9
Stroke 1074 (7.09) 651 (9.39) 102 (15) 65 (11.5)
PAD 5519 (36.4) 2859 (41.2) 247 (36.4) 214 (37.9)
Smoking 9767 (65.2)170 3157 (46.1)86 499 (74.7)10 348 (62.4)6
COPD 2777 (22.4)2777 1512 (26.2)1157 158 (27.2)97 170 (35.1)79
Treated diabetes 3126 (21.2)381 1673 (24.6)133 203 (30.8)18 200 (35.8)6
Renal disease 749 (4.94) 338 (4.88) 89 (13.1) 61 (10.8)
Clinical presentation
Emergency surgery 217 (1.43) 119 (1.72) 27 (3.98) 23 (4.08)
Procedures
Surgery type
CABG 7652 (50.5) 2337 (33.7) 433 (63.9) 255 (45.2)
Valve 4416 (29.1) 3036 (43.8) 152 (22.4) 204 (36.2)
Combined 3088 (20.4) 1559 (22.5) 93 (13.7) 105 (18.6)
Reoperation 3790 (25) 1496 (21.6) 95 (14) 90 (16)
LV indicates left ventricular; PAD, peripheral arterial disease; COPD, chronic obstructive pulmonary disease; and CABG, coronary artery bypass grafting. For
continuous variables, 50th (25th, 75th) percentiles are presented; for categorical variables, counts (proportion) are presented. The number of missing or nonapplicable
values is shown in superscript.
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additional analyses: (5) subclassifying male patients on generalized
propensity scores of both race and SEP Z score and comparing the 2
causal effects; and (6) similar analyses among women. The causal
effects of race and SEP were visually illustrated and compared in a
plot of Kaplan-Meier survival curves before and after matching on
race (Figure 6) and a plot of predicted 5-year survival calculated
from the models in analyses (5) and (6) (Figure 7). The results of
analyses (1) through (6) are included in Tables 3, 4, and 5.
Figure 2. Distributions of 6 components of the SEP score (histograms) of the patient population in comparison with the corresponding
distributions in the general US population (red line).
Figure 3. Probability density distributions (histograms) of the 6 components of SEP score, stratified by 4 race-sex groups: Women are
indicated by red; men, blue; black patients, solid line; and white patients, dashed line. Whiskers along the horizontal axis are the cut-
points used to define the histogram.
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The propensity score matching generally followed the proposal by
Rosenbaum and Rubin.3 The generalized propensity score subclas-
sification generally followed the proposal by Imai and van Dyk.4
Further details on these procedures are included in the Online Data
Supplement.
The outcome variable of analyses (1) through (6) was survival,
because it has been found in previous studies that the effect of
prognostic factors on survival after cardiac surgery often vary over
an extended follow-up period, thus violating the proportional hazard
assumption of the standard Cox model. Based on an unadjusted
Kaplan-Meier analysis, an early high-risk phase of mortality ex-
tended from operation to approximately 6 months, at which time this
phase transitioned to a lower phase of risk. Thus, we used a
time-segmented 2-phase Cox model. The early phase was a Cox
model within the first 6 months of operation. If the patient was still
alive at 6 months, that patient’s data were artificially right-censored.
The late phase was a Cox model applied to data beyond 6 months,
excluding those who died or were lost to follow-up within the first 6
months.
There were sporadic missing data for some clinical variables that
were imputed 5 times by multiple imputations. All above analyses,
except the descriptive statistics, were repeated 5 times with the 5
imputed data sets.
All results in this report were from combined analyses of the 5
imputations unless otherwise noted. Probability values 0.05 were
considered statistically significant. Because this is an observational
cohort study with prespecified end points, no adjustment for multiple
probability values was used. The statistical analysis was performed
by SAS 9.1 and R 2.6.2.
Results
Race–Sex Diversity
White women were older on average than the other race-sex
groups; black men had higher baseline creatinine values and
more prior myocardial infarctions; and both black women and
men more frequently had left ventricular dysfunction, more
heart failure, higher NYHA functional class IV symptoms,
and more frequently presented for emergency surgery com-
pared with either white women or white men (Table 1). In
addition, black women and black men had more hyperten-
sion, prior stroke, treated diabetes, and renal disease com-
pared with white women and white men.
Correlates of SEP
The SEP of the study population was generally slightly higher
than the general US population (Figure 2). SEP was lowest
Figure 4. Probability distribution (left) and cumulative probability distribution (right) of the SEP Z score, stratified by 4 race-sex groups:
Women are indicated by red; men, blue; black patients, solid line; and white patients, dashed line.
Figure 5. Kaplan-Meier survival curves
by race-sex groups (left) and SEP
groups (right). SEP groups were defined
by 20th, 40th, 60th, and 80th percentiles
of the marginal distribution of the SEP Z
score.
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among black patients and women for all 6 indicators: median
income, median home value, percent high school and college
graduates, percent in managerial positions and percent receiv-
ing dividend income (Figure 3). As a result, blacks and
women had lower overall SEP Z scores compared with white
patients and men (Figure 4).
Unadjusted Survival
There were differences in survival among the four sex-race
groups (Figure 5A, P0.0001). White women had worse
survival than white men and black men had the worst overall
survival after surgery. To at least 10 years after surgery,
patients with lower SEP had worse survival than those with
higher SEP, in a near dose-response fashion (Figure 5B,
P0.0001).
Causal Effect of Race and SEP on Survival
No statistically significant effect of race was identified in the
propensity score–matched data (Table 3 and Figure 6). In
contrast, a decreasing level of SEP demonstrated a causal
effect, by stratified Cox regression (Table 4). Specifically,
both men and women in lower SEP had higher hazard and
thus worse long-term survival. The direction of this effect
was the same in the early phase, but SEP was not statistically
significant, suggesting that clinical variables played a larger
role than SEP in recovery from surgery.
The causal effects of race and SEP in Tables 3 and 4 are not
directly comparable because Table 3 was based on the subset
of matched data and Table 4 on a particular stratification of
the entire population. To better compare the magnitude of
these 2 causal effects, we conducted a generalized propensity
score analysis of the 2 factors simultaneously as detailed in
the Online Data Supplement. This analysis corroborated the
stratified analyses (Table 5), but in addition revealed that any
interaction between race and SEP was not statistically signif-
icant. A visual illustration of the relative magnitude of the
causal effects of race and SEP, based on these results, is
presented in Figure 7. The horizontal axis represents the
percent of patients in the study sample that had lower SEP
Z score than a hypothetical patient. As the hypothetical
patient’s SEP increases, survival increases steadily. Race
of the hypothetical patient predicts somewhat different
increases in survival among men and women, but this




The present large study revealed surprising results concerning
disparities in SEP in patients with cardiovascular disease
undergoing cardiac surgery and has provided a link between
these disparities and death. Patients with lower SEP were
more commonly female, black, and had more cardiovascular
disease burden. On presentation for surgery, these groups of
socioeconomically disadvantaged patients had more heart
failure, more symptoms, and more comorbidity. Mediating
pathways between demographics, SEP, and processes that
Table 2. Factors Associated With Overall Socioeconomic
Position Z Score
Predictor Coefficient Standard Error P Value
Demographics
White male 0
White female 0.93 0.086 0.0001
Black male 4.74 0.20 0.0001
Black female 5.48 0.22 0.0001
Age, y 0.023 0.0031 0.0001
Body mass index, kg/m2 0.052 0.0064 0.0001
Cardiac morbidity
Prior myocardial infarction 0.45 0.075 0.0001
Abnormal LV function 0.44 0.072 0.0001
Heart failure 0.70 0.082 0.0001
NYHA functional class 1 0
NYHA functional class 2 0.43 0.094 0.0001
NYHA functional class 3 0.86 0.11 0.0001
NYHA functional class 4 1.11 0.12 0.0001
Atrial fibrillation 0.078 0.13 0.55
Carotid disease 0.18 0.18 0.31
Aortic valve regurgitation 0.19 0.085 0.026
Aortic valve stenosis 0.25 0.092 0.0068
Mitral valve regurgitation 0.43 0.082 0.0001
Mitral valve stenosis 0.90 0.17 0.0001
Tricuspid valve regurgitation 0.22 0.086 0.0097
Coronary disease 70% stenosis
Left main trunk 0.16 0.13 0.23
Left anterior descending 0.23 0.088 0.010
Left circumflex 0.18 0.084 0.034
Right coronary artery 0.28 0.088 0.0018
Comorbidity
Hypertension 0.29 0.078 0.0002
Stroke 0.37 0.12 0.0028
PAD 0.62 0.18 0.0004
Smoking 0.45 0.070 0.0001
COPD 0.67 0.081 0.0001
Treated diabetes 0.68 0.086 0.0001
Renal disease 0.40 0.18 0.021
Preoperative laboratory values
Hematocrit, % 0.0065 0.0077 0.40
Creatinine, mg/dL* 0.15 0.11 0.18
Bilirubin, mg/dL* 0.16 0.068 0.016
Clinical presentation
Emergency surgery 0.32 0.26 0.22
LV indicates left ventricular; PAD, peripheral arterial disease; and COPD,
chronic obstructive pulmonary disease. The SEP Z scores of this population
have approximately normal distribution with mean 0 and interquartile range
6.8. A negative coefficient indicates that increased value of the (continuous)
variable or presence of the condition (binary) is associated with decreased
socioeconomic position.
*Log-transformed value was used.
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contribute to cardiovascular disease are uncertain.5 Others
have noted that patients of low SEP are at higher cardiovas-
cular disease risk despite the fact that the measurement is
crudely related to biological processes.6
Unadjusted survival was lowest for black men compared with
other sex-race groupings, and white men had the best
survival for the duration of the follow-up period. Lower
survival for white women compared with white men is
concerning because women have better expected survival
than men in the general population.7 Although SEP was the
driving determinant of risk-adjusted survival rather than
race per se, black patients were disproportionately repre-
sented in lower SEP. This socioeconomic disparity, when
present, was associated with similar early risks of surgery
but increased late risk of death for at least 10 years, the
duration of follow-up period.
Figure 6. Kaplan-Meier survival curves
with point-wise 95% confidence intervals
by race (solid line, black patients;
dashed line, white patients) for men (A,
blue) and women (B, red), before and
after propensity score matching.
Figure 7. Five-year risk-adjusted survival stratified by race and SEP. A, Among men, light blue indicates white patients; blue, black
patients. B, Among women, light red indicates white patients; red, black patients. Vertical bars represent 95% confidence intervals. The
baseline (white patients, SEP Z score0) 5-year survival is assumed to be 85%.
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Immediate Postoperative Outcome
Our investigation demonstrated similar immediate postoper-
ative outcomes among patients of differing SEP. A systematic
bias against patients of low SEP with regard to perioperative
management decisions is unlikely because patients come to
surgery with a well-defined disease necessitating a specific
well-standardized surgical intervention. Among limitations
with prior work has been an exclusion of SEP or race from
statistical modeling, as well as use administrative data sets,
which have inherent limitations. Hartz et al8 reported higher
risk-adjusted operative mortality for women and non-white
race in CABG patients from the Society of Thoracic Surgeons
database; however, their investigation did not account for
indicators of SEP. Similarly, SEP information was not in-
cluded in the analysis of data from the Coronary Artery
Surgery Study (CASS), in which higher mortality was noted
among African Americans.9 Race was a significant risk factor
influencing outcomes in a Veterans Health Administration
data set, in which the authors examined effects of African
American race and Hispanic American ethnicity on mortality
and complications in CABG surgery.10 Outcomes included
30-day and 6-month mortality and 30-day complications. The
authors reported lower 30-day mortality risk for Hispanic
American ethnicity compared with white patients. African
American patients had similar risk-adjusted 30-day and
6-month mortality. However, among low-risk surgical pa-
tients, African American race was associated with higher
mortality and more postoperative complications.10
Finally, in an administrative data set of Medicare benefi-
ciaries, Konety et al11 examined race-related disparities in
mortality and repeat revascularization after CABG. SEP was
measured by incorporating zip code–level median household
income. Although their data set was incomplete in terms of
important clinical variables associated with survival such as
left ventricular ejection fraction, they reported similar risk-
adjusted in-hospital mortality among blacks and whites after
adjusted for household income. However, survival 1 year
after surgery was lower for black patients, leading the authors
to speculate that blacks received suboptimal care after
surgery.11
Long-Term Survival
Our investigation reported a risk-adjusted reduction in long-
term survival for patients of lower SEP out to 10 years of
follow-up. Zacharias et al12 used Medicaid status as a
surrogate for SEP. Similar to our investigation, race was not
associated with worse operative or late outcomes after
CABG; rather, Medicaid status, which was more common
among African-Americans, was associated with worse late
survival.
In contrast, Gray et al13 reported higher risk-adjusted
long-term mortality at 1 and 5 years for blacks in a predom-
inantly medically insured patient population after CABG.
Similarly, Brooks et al14 identified black race as an important
factor associated with increased risk for mortality in the
Bypass Angioplasty Revascularization Investigation (BARI).
Five-year mortality was associated with a number of factors
including black race; however, SEP information was not
analyzed in their study.14
Guru et al15 reported higher early mortality for women and
similar long-term mortality risk for women and men after
CABG. However, when they examined a subset of patients
with body surface area data and SEP information, women
were not at greater early risk for death. It appeared that only
income data were available for SEP information. The authors
did not indicate whether SEP predicted survival after
CABG.15 Other investigations have reported higher in-
hospital mortality for women after surgery16,17 and less
functional recovery,18,19 whereas others report similar out-
comes for women and men.20,21 Much of this variability may
result from lack of complete SEP and race information for
statistical modeling.
Clinical Implications
In a review of surgical outcomes in African Americans,
Bridges22 noted that despite publications reporting higher risk
Table 3. Association of Race on Risk of Mortality Among Men and Women After Propensity Score Matching
Population
Early Risk of Mortality (6 mo) Late Risk of Mortality (6 mo)
Estimate† Lower CL Upper CL P Estimate† Lower CL Upper CL P
Among men (1292–1328)* 0.11 0.54 0.32 0.61 0.052 0.19 0.30 0.67
Among women (1024–1048)* 0.43 0.94 0.071 0.091 0.16 0.44 0.12 0.25
CL indicates 95% confidence limits.
*Minimum and maximum sample sizes of 5 matched data sets in which white and black patients were matched in 1:1 ratio.
†Estimates represent the log hazard ratio of race in the Cox model, black versus white.
Table 4. Association of SEP Z Score on Risk of Mortality Among Men and Women After Subclassification by Generalized Propensity Score
Population
Early Risk of Mortality (6 mo) Late Risk of Mortality (6 mo)
Estimate† Lower CL Upper CL P Estimate† Lower CL Upper CL P
Among men (3805/15834)* 0.0090 0.024 0.0065 0.25 0.018 0.025 0.011 0.0001
Among women (2211/7496)* 0.010 0.028 0.0084 0.29 0.014 0.025 0.0037 0.0079
CL indicates 95% confidence limits.
*Number of deaths per sample size.
†Estimate represents the log hazard ratio of Z in the Cox model.
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for African Americans, these studies were limited by failure
to adjust for socioeconomic status and failed to examine
disparities in postoperative medical care. Our results indicate
that when risk-adjusted for comorbidity, perioperative fac-
tors, and SEP, early and late survival for black and white
patients is similar. That is, white patients of low SEP have
equal decrement in survival to black patients. Socioeconomic
disparity clearly influences an individual patient’s health,5
and in our investigation this is reflected in inferior survival
after cardiac surgery for socioeconomically disadvantaged
patients. Hence, although it is convenient to label patients by
skin color and sex, it is factors that relate to SEP (poor
education, low income, inadequate housing, lack of discre-
tional funds for investment, and not being “in charge” at
work) that are more important.
A recent commentary on lack of progress in reducing
health care disparities noted that disparities in health care
involve patient-level factors as well as provider and health
care system factors.23 An intense focus should be directed
toward socioeconomically disadvantaged patients; regardless
of race and patient and health system factors that create
disparity in health outcomes. We can only speculate on
process of care factors in the postoperative follow-up period
that may confer a survival disadvantage for patients of lower
SEP. Cardiac rehabilitation is known to reduce mortality
rates, improve functional outcomes, and contribute to better
management of risk factors; yet, despite these benefits, it is
considerably underused.24–26 It is important to note that
patients with lower SEP are reported to participate less in
cardiac rehabilitation programs.27,28 These findings present an
opportunity for targeted intervention to increased referral to
cardiac rehabilitation, which is currently underused by disad-
vantaged patients. A recent editorial notes that socioeconomic
issues coupled with access to care and completeness of
coverage must be addressed.29 The authors suggest that these
may facilitate a more proactive approach to risk factor
management, which could lead to better health outcomes.29
Limitations
This investigation was from a single quaternary referral
center, and results may not be broadly generalizable. How-
ever, patients in our investigation were largely representative
of the spectrum of SEP distributions for all 6 SEP indicators
(see Figure 2). Although the Society of Thoracic Surgeons
National Cardiac Surgery Database has a number of risk
factors, it is deidentified, so socioeconomic data are unavail-
able. We are able to only speculate on the reasons for the
strong influence of SEP on survival in our patient population
because this was a cohort investigation. Although our patient
sample size was large and data registries detailed and pro-
spectively collected, we did not have information on longi-
tudinal care after discharge, such as participation in cardiac
rehabilitation programs, or whether this group had less access
to follow-up care and secondary prevention education. Cer-
tainly these factors could influence outcomes. Additionally,
SEP is a multidimensional construct, and data on individual
level education, power, social class, and prestige were not
assessed on hospital admission.30 However, census block data
have been shown to be a powerful predictor of coronary
artery disease and cardiovascular outcomes and have an
excellent correlation with individual-level SEP.2,31,32 Further-
more, it has been argued that census block socioeconomic
data as a surrogate for individual level SEP may actually
underestimate the severity of individual level SEP.2,32 Unique
features of our investigation are the ability to examine and
model SEP as it relates to both sex and race in addition to the
detailed and in-depth data on the perioperative state of the
patient. We are among the busiest heart centers in the United
States, and the number of cases allowed us to examine in
detail the interplay of race, sex, SEP, and comorbidity on
survival.
Blacks constituted a small portion of the data, which
decreases statistical power of the analysis of race. This is
evident in Figure 7, in which the confidence intervals of the
black population are much wider than those of the white
population. The smaller sample size of black patients influ-
ences the power of both unadjusted and causal analyses.
However, in the unadjusted analysis of race, the difference in
survival was significant between black and white men, but
that difference diminished in the causal analyses. In contrast,
in the unadjusted analysis of SEP, the difference was signif-
icant across SEP levels, and that difference remained signif-
icant in the causal analyses. Note that the causal analysis in
this report was performed with propensity score methods,
which are valid only when all confounders were properly
accounted for. For demographic risk factors such as race, it is
impossible to exhaust all the quantities relevant to both race
and mortality in the propensity score model. We have
deliberately selected well-established strong risk factors for
the CABG/valve surgery patients. Therefore, the estimated
Table 5. Association of Both SEP Z Score and Race on Risk of Mortality, After Subclassification by Generalized Propensity Scores
Population
Early Risk of Mortality (6 mo) Late Risk of Mortality (6 mo)
Estimate* Lower CL Upper CL P Estimate* Lower CL Upper CL P
Among men
Race (black vs white) 0.069 0.26 0.40 0.68 0.090 0.080 0.26 0.30
SEP Z score 0.011 0.027 0.0045 0.16 0.019 0.026 0.011 0.0001
Among women
Race (black vs white) 0.25 0.61 0.10 0.16 0.15 0.36 0.054 0.15
SEP Z score 0.0088 0.028 0.010 0.36 0.014 0.025 0.0034 0.010
CL indicates 95% confidence limits.
*Estimate represents the log hazard ratio of Z in the Cox mode.
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causal effect in this report is interpretable only in reference to
these confounders.
Conclusion
We have linked disparity in SEP to survival after cardiac
surgery. Although black patients and women had signifi-
cantly lower SEP, when survival was adjusted for traditional
risk factors and patient SEP, race was not a risk factor for
survival; rather, low SEP remained a significant predictor for
reduced survival. Factors that link SEP and survival are
unclear, and the influence on long-term follow-up should be
an area for future investigation. Changes in time-related
survival for patients of low SEP necessitate a change in our
approach to health care delivery because low SEP places the
patient at risk for death out to 10 years after surgery. This
necessitates access and delivery of primary prevention, early
identification of cardiovascular risk factors and effective
delivery of secondary prevention, and access to long-term
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